CoronaryAtlas logo
CoronaryAtlas
Cathepsin D
Pathway / Fibrous-cap degradation & rupture

Cathepsin D

CTSDprotein

Cathepsin D degrades extracellular-matrix proteins in atherosclerotic plaques and mediates macrophage apoptosis post-MI, influencing plaque stability and myocardial remodeling.

Pathway placement
Cascade stepFibrous-cap degradation & rupture
Confidencehigh
RationaleMatrix protease; atherosclerosis progression marker; expressed in macrophages and contributes to fibrous-cap degradation.
Also acts inVascular inflammation, Myocardial injury
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000117984

Type I vs Type II discrimination

ScoresLow-confidence (proxy)
R — rupture / Type-I
37
C — confounder / Type-II
69
A — assay feasibility
68
E — evidence strength
26
T1DI (composite)
6
Specificity differential (R−C)-32
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)

Literature evidence(6)